IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Serum Interleukin-2 Level Associated with Treg/Th17 Ratio in Active Systemic Lupus Erythematosus

Author: RIARITA SUBAMAYANTI, YULIASIH, LITA DIAH RAHMAWATI
Abstract: Introduction: Systemic lupus erythematosus (SLE) is resulted from loss of immunological tolerance. Interleukin-2 (IL-2) plays an important role in loss of tolerance in SLE through its influence on Treg and Th17 balance. This study was conducted to determine the correlation between serum IL-2 level with Treg/Th17 ratio in active SLE. Methods: This cross-sectional analytic study included thirty newly diagnosed SLE patients. IL-2 level was measured using ELISA, whereas Treg and Th17 expressions were measured using the flow cytometry method, then the ratio was calculated. The Systemic Lupus Activity Measure (SLAM) scores were used to assessed SLE disease activity. Results: All patients were female with mean age of 31±10 years. Hematological conditions and arthritis were the most prominent clinical manifestations. All patients were in active SLE conditions with a high mean SLAM score of 29±4. Serum IL-2 level was lower in SLE patients compared to healthy subjects (median 7.12 pg/mL vs 49.31 pg/mL, respectively). Treg/Th17 ratio was also lower in SLE patients compared to healthy subjects (median 0.405 vs 0.830, respectively). There was a significant correlation between serum IL-2 level with Treg/Th17 ratio (r = 0.463; P = 0.01). Conclusion: Serum IL-2 level is associated with Treg/Th17 ratio in active SLE.
Keyword: SLE, IL-2, Treg/Th17 ratio, disease activity, SLAM.
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free